After the launch of the ANMOL scheme to provide screening tests for genetic and metabolic disorders in newborns, medical ...

Preterm babies face greater health risks from the moment they are born. Their organs, immune systems, and metabolic pathways are not fully developed, making them more vulnerable to complications.

Just six months after a newborn at Children's Hospital of Philadelphia was diagnosed with a rare and life-threatening metabolic disorder, doctors were able to develop a personalized treatment ...

Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of brain functions. The drug fosdenopterin/rcPMP ...

The ANMOL scheme introduces free genetic and metabolic screening for newborns in both public and private hospitals. It aims ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...